Abstract
Alzheimer’s disease (AD) is a devastating illness, affecting over 5.5 million adults in the United States and costing over 170 billion dollars annually. In addition, there is growing recognition that mild cognitive impairment (MCI) constitutes a risk factor for AD and other neurodegenerative disorders. In this chapter, we describe the clinical manifestations of early AD and other neurogenerative brain disorders and describe the appropriate neuropsychological measures that tap the important cognitive domains that should be assessed in these conditions. A summary of useful clinical tips as well as future directions in the field are addressed.
Keywords
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alzheimer’s Association. Alzheimer’s disease facts and figures. Alzheimers Dement. 2010;6:158–94.
Park D, Schwartz N. Cognitive aging: a primer. Philadelphia: Taylor and Francis (Psychology Press); 2000.
Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA. Alzheimer’s disease in the U.S. population: prevalence estimates using the 2000 census. Arch Neurol. 2003;60:1119–22.
Iqbal K, Liu F, Gong CX, Alonso Adel C, Grundke-Iqbal I. Mechanisms of tau induced neurodegeneration. Acta Neuropathol. 2009;118(1):53–69.
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan E. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer’s disease. Neurology. 1984;34:939–44.
McKhann G, Knopman D, Chertkow H, Hyman BT, Jack CR, Kawas KH, Klunk WE, Koroshetz WJ, Manley JJ, Mayeux R, Mohs RC, Morris JC, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institutes on Aging-Alzheimer’s Association workgroup on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7(3):263–9.
Brooks LG, Loewenstein DA. Assessing the progression of mild cognitive impairment (MCI) to Alzheimer’s disease: current trends and future directions. Alzheimers Res Ther. 2010;2:28.
Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56:303–8.
Petersen RC. Mild cognitive impairment: transition between aging and Alzheimer’s disease. Neurologia. 2000;15:93–101.
Grober E, Lipton RB, Hall C, et al. Memory impairment on free and cued selective reminding predicts dementia. Neurology. 2000;54:827–32.
Howieson DB, Dame A, Camicioli R, et al. Cognitive markers preceding Alzheimer’s dementia in the healthy oldest old. J Am Geriatr Soc. 1997;45:584–9.
Small BJ, Mobly JL, Laukka EJ, Jones S, Backman L. Cognitive deficits in preclinical Alzheimer’s disease. Acta Neurol Scand Suppl. 2003;179:29–33.
Assal F, Cummings JL. Neuropsychiatric symptoms in the dementias. Curr Opin Neurol. 2002;15:445–50.
Luis CA, Loewenstein DA, Acevedo A, Barker WW, Duara R. Mild cognitive impairment: directions for future research. Neurology. 2003;61:438–44.
Morris JC, Storandt M, Miller JP, McKeel DW, Price JL, Rubin EH, Berg L. Mild cognitive impairment represents early-stage Alzheimer’s disease. Arch Neurol. 2001;58(3):397–405.
Larrieu S, Letenneur L, Orgogozo JM, Fabrigoule C, Amieva H, Le Carret N, Barberger-Gateau P, Dartigues JF. Incidence and outcome of mild cognitive impairment in a population-based prospective cohort. Neurology. 2002;59:1594–9.
Petersen R. Mild cognitive impairment. J Intern Med. 2004;256:183–94.
Loewenstein DA, Amarilis Acevedo A, Small BJ, Agron J, Crocco E, Duara R. Stability of different subtypes of mild cognitive impairment among the elderly over a two to three year follow-up period. Dement Geriatr Cogn Disord. 2009;17(5):437–40.
Alexopoulos P, Grimmer T, Perneczky R, Domes G, Kurz A. Progression to dementia in clinical subtypes of mild cognitive impairment. Dement Geriatr Cogn Disord. 2006;22:27–34.
Rountree SD, Waring SC, Chan WC, Lupo PJ, Darby EJ, Doody RS. Importance of subtle amnestic and nonamnestic deficits in mild cognitive impairment: prognosis and conversion to dementia. Dement Geriatr Cogn Disord. 2007;24:476–82.
Manly JJ, Tang MX, Schupf N, Stern Y, Vonsattel JP, Mayeux R. Frequency and course of mild cognitive impairment in a multiethnic community. Ann Neurol. 2008;63:494–506.
Ritchie LJ, Tuokko H. Patterns of cognitive decline, conversion rates, and predictive validity for 3 models of MCI. Am J Alzheimers Dis Other Demen. 2010;25(7):592–603.
Locasio JJ, Growdon JH, Corkin S. Cognitive test performance in detecting, staging, and tracking Alzheimer’sdisease. Arch Neurol. 1995;52:1087–99.
Tröster AI, Butters N, Salmon D, Cullum CM, Jacobs D, Brandt J, White RF. The diagnostic utility of savings scores: differentiating Alzheimer’s and Huntington’s disease with the logical memory and visual reproduction tests. J Clin Exp Neuropsychol. 1993;5:773–88.
Christensen H, Kopelman MD, Stanhope N, Lorentz L, Owen P. Rates of forgetting in Alzheimer dementia. Neuropsychologia. 1998;36:547–57.
Loewenstein DA, Acevedo A, Luis CA, Crum T, Barker WW, Duara R. Semantic interference deficits and the detection of mild Alzheimer’s disease and mild cognitive impairment without dementia. J Int Neuropsychol Soc. 2004;1:91–100.
Delis DC, Kramer JH, Kaplan E, Ober BA. California verbal learning test- second edition. San Antonio: The Psychological Corporation; 2000.
Rey A. L’examen Clinique en psychologie. Paris: Presses Universitaries de France; 1964.
Lezak MD. Neuropsychological assessment. New York: Oxford University Press; 1998.
Benedict R, Schretlen D, Groninger L, et al. Hopkins Verbal Learning Test—Revised: normative data and analysis of inter-form and test-retest reliability. Clin Neuropsychol. 1998;12:43–55.
Fuld PA. Fuld object-memory evaluation. Chicago: Stoelting Co; 1981.
Loewenstein DA, Arguelles T, Barker WW, et al. The utility of a modified Object Memory Test in distinguishing between three different age groups of Alzheimer’s disease patients and normal controls. J Mental Health Aging. 2001;7:317–24.
Loewenstein DA, Acevedo A, Agron J, Duara R. Vulnerability to proactive semantic interference and progression to dementia older adults with mild cognitive impairment (MCI). Dement Geriatr Cogn Disord. 2007;24(5):363–8.
Wechsler D. The Wechsler Memory Scale. 4th ed. San Antonio: The Psychological Corporation; 2008.
Benedict R. Brief Visual Memory Test. Odessa: Psychological Assessment Resources; 1996.
Goodglass H, Kaplan E, Weintraub S. The Boston Naming Test. Philadelphia: Lea and Febiger; 1983.
Monsch AY, Bondi MW, Butters N, Salmon DP, Katzman R, Thal L. Comparison of verbal fluency tasks in the detection of dementia of the Alzheimer’s type. Arch Neurol. 1992;49(12):1253–8.
Spreen O, Strauss E. A compendium of neuropsychological tests: administration, norms, and commentary. 2nd ed. New York: Oxford University Press; 1998.
Benton A, des Hamsher K, Sivan AB. Multilingual aphasia examination. Iowa City: AJA Associates; 1994.
Heaton RK, Chelune GJ, Talley JL, Kay GG, Curtiss G. Wisconsin Card Sorting Test manual: revised and expanded. Odessa: Psychological Assessment Resources; 1993.
War Department Adjutant General’s Office. Army Individual Test Battery. Manual of directions and scoring. Washington, DC: War Department Adjutant General’s Office; 1944.
Reitan RM, Wolfson D. The Halstead-Reitan neuropsychological test battery: theory and clinical interpretation. 2nd ed. Tucson: Neuropsychology Press; 1993.
Wechsler D. The Wechsler Adult Intelligence Scale. 4th ed. San Antonio: The Psychological Corporation; 2008.
Benton A, Sivan AG, des Hamsher K, Varney NR, Spreen O. Contributions to neuropsychological assessment: a clinical manual. 2nd ed. Oxford: London; 1994.
Hooper HE. Hooper Visual Organization Test (VOT). Los Angeles: Western Psychological Services; 1983.
Landau SM, Harvey D, Madison CM, Reiman EM, Foster NL, Aisen PS, Petersen RC, Shaw LM, Trojanowski JQ, Jack Jr CR, Weiner MW, Jagust WJ. Comparing predictors of conversion and decline in mild cognitive impairment. Neurology. 2010;75:230–8.
Albert MS, Dekosky ST, Dicksen D, Dubois B, Feldman HH, Fox N, Gamst A, Holtzman D, Jagust WJ, Petersen R. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging and Alzheimer’s Association workgroup. Alzheimer’s & Dementia; 2011. p. 1–10.
American Psychiatric Association. Task force on DSM-IV: diagnostic and statistical manual of mental disorders: DSM-IV. 4th ed. Washington, DC: American Psychiatric Association; 1994.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Loewenstein, D. (2013). Assessment of Alzheimer’s Disease. In: Ravdin, L., Katzen, H. (eds) Handbook on the Neuropsychology of Aging and Dementia. Clinical Handbooks in Neuropsychology. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-3106-0_18
Download citation
DOI: https://doi.org/10.1007/978-1-4614-3106-0_18
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-3105-3
Online ISBN: 978-1-4614-3106-0
eBook Packages: Behavioral ScienceBehavioral Science and Psychology (R0)